Heparanase‐Expressing Regulatory T Cells Drive Immunotherapy Resistance and Poor Outcomes in Lung Cancer

Heparan sulfate proteoglycans (HSPGs) and their degrading enzyme heparanase (Hpse) play pivotal roles in tumor invasion and metastasis. Previous studies have reported associations between Hpse expression in tumor cells and patient prognosis. Although immune checkpoint inhibitors (ICIs) are a cornerstone of solid tumor therapy, the role of Hpse in antitumor immunity remains unclear. Here, we examined Hpse localization and its impact on the immune microenvironment in lung adenocarcinoma. To investigate the relationships among the Hpse expression, tumor prognosis, and tumor‐infiltration of immune cells, an immunohistochemical analysis of Hpse1, Hpse2, regulatory T cells (T reg s), macrophages, and CD8 + T cells was performed in resected tumor tissue from lung adenocarcinoma patients. The effects of the Hpse inhibitor PG545 on the invasive capabilities of lymphocytes were investigated. In lung adenocarcinoma tissues, Hpse1 and Hpse2 were expressed in both epithelial tumor cells and immune cells. A high Hpse1 expression and low Hpse2 expression are poor postoperative prognostic factors in both epithelial cells and tumor‐infiltrating hematopoietic cells. Single‐cell RNA sequencing of human tumor‐infiltrating immune cells revealed that T reg s and some subclusters of macrophages specifically express Hpse1. Lung adenocarcinoma tissue with high Hpse‐expressing immune cells demonstrated an increase in tumor‐infiltrating T reg s. PG545 suppressed the invasion of T reg s toward the HSPG‐containing ECM. Furthermore, PG545 suppressed tumor progression and infiltration of T reg s in a mouse model. In addition, PG545 reinforced antitumor effects of PD‐L1 blockade. Hpse expression in T reg s has a significant impact on lung cancer progression and is a promising therapeutic target for novel combination immunotherapy.

Authors

Institutions

Publication Details

Journal
International Journal of Cancer
Published
2026-11-18
DOI
https://doi.org/10.1002/ijc.70824
Primary Topic
Proteoglycans and glycosaminoglycans research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Heparanase‐Expressing Regulatory T Cells Drive Immunotherapy Resistance and Poor Outcomes in Lung Cancer

Atsushi Mitsuhashi, Hiroshi Nokihara, Yasuhiko Nishioka, Yohei Yabuki et al.
International Journal of Cancer
Proteoglycans and glycosaminoglycans research
article

Heparanase‐Expressing Regulatory T Cells Drive Immunotherapy Resistance and Poor Outcomes in Lung Cancer

Atsushi Mitsuhashi, Hiroshi Nokihara, Yasuhiko Nishioka, Yohei Yabuki, Yuki Tsukazaki, Israël Vlodavsky, Hiromitsu Takizawa, Neta Ilan, Hirokazu Ogino, Ryohiko Ozaki, Tsutomu Shinohara, Seidai Sato, Masaki Hanibuchi, Kazuya Koyama, Aito Yoshida, Yutaka Morita
article en

Abstract

Heparan sulfate proteoglycans (HSPGs) and their degrading enzyme heparanase (Hpse) play pivotal roles in tumor invasion and metastasis. Previous studies have reported associations between Hpse expression in tumor cells and patient prognosis. Although immune checkpoint inhibitors (ICIs) are a cornerstone of solid tumor therapy, the role of Hpse in antitumor immunity remains unclear. Here, we examined Hpse localization and its impact on the immune microenvironment in lung adenocarcinoma. To investigate the relationships among the Hpse expression, tumor prognosis, and tumor‐infiltration of immune cells, an immunohistochemical analysis of Hpse1, Hpse2, regulatory T cells (T reg s), macrophages, and CD8 + T cells was performed in resected tumor tissue from lung adenocarcinoma patients. The effects of the Hpse inhibitor PG545 on the invasive capabilities of lymphocytes were investigated. In lung adenocarcinoma tissues, Hpse1 and Hpse2 were expressed in both epithelial tumor cells and immune cells. A high Hpse1 expression and low Hpse2 expression are poor postoperative prognostic factors in both epithelial cells and tumor‐infiltrating hematopoietic cells. Single‐cell RNA sequencing of human tumor‐infiltrating immune cells revealed that T reg s and some subclusters of macrophages specifically express Hpse1. Lung adenocarcinoma tissue with high Hpse‐expressing immune cells demonstrated an increase in tumor‐infiltrating T reg s. PG545 suppressed the invasion of T reg s toward the HSPG‐containing ECM. Furthermore, PG545 suppressed tumor progression and infiltration of T reg s in a mouse model. In addition, PG545 reinforced antitumor effects of PD‐L1 blockade. Hpse expression in T reg s has a significant impact on lung cancer progression and is a promising therapeutic target for novel combination immunotherapy.

International Journal of Cancer
Technion – Israel Institute of Technology (IL), National Center for Global Health and Medicine (JP), Center Hospital of National Center for Global Health and Medicine (JP), Tokushima University (JP)
Proteoglycans and glycosaminoglycans research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon